Price
CHART BY
Frequently asked questions
What is BeOne Medicines Ltd. Sponsored ADR's market capitalization?
The market capitalization of BeOne Medicines Ltd. Sponsored ADR is $36.13B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is BeOne Medicines Ltd. Sponsored ADR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for BeOne Medicines Ltd. Sponsored ADR is 60.89. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for BeOne Medicines Ltd. Sponsored ADR?
BeOne Medicines Ltd. Sponsored ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.69. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for BeOne Medicines Ltd. Sponsored ADR's stock?
Currently, 32 analysts cover BeOne Medicines Ltd. Sponsored ADR's stock, with a consensus target price of $434.95. Analyst ratings provide insights into the stock's expected performance.
What is BeOne Medicines Ltd. Sponsored ADR's revenue over the trailing twelve months?
Over the trailing twelve months, BeOne Medicines Ltd. Sponsored ADR reported a revenue of $6.14B.
What is the EBITDA for BeOne Medicines Ltd. Sponsored ADR?
BeOne Medicines Ltd. Sponsored ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.08B. EBITDA measures the company's overall financial performance.
What is the free cash flow of BeOne Medicines Ltd. Sponsored ADR?
BeOne Medicines Ltd. Sponsored ADR has a free cash flow of $1.33B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does BeOne Medicines Ltd. Sponsored ADR have, and what sector and industry does it belong to?
BeOne Medicines Ltd. Sponsored ADR employs approximately 12,000 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of BeOne Medicines Ltd. Sponsored ADR's shares?
The free float of BeOne Medicines Ltd. Sponsored ADR is 103.72M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $36.13B
- EPS (TTM)
- $5.69
- Free Float
- 103.72M
- P/E ratio (TTM)
- 60.89
- Revenue (TTM)
- $6.14B
- EBITDA (TTM)
- $1.08B
- Free Cashflow (TTM)
- $1.33B
Pricing
- 1D span
- $340.03$349.53
- 52W span
- $253.96$385.00
Analyst Ratings
The price target is $434.95 and the stock is covered by 32 analysts.
Buy
30
Hold
2
Sell
0
Information
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
- Employees
- 12,000
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- BGNE
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet